List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
11 April 2016 | By Victoria White, Digital Content Producer
New research could pave the way for a new generation of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
17 March 2016 | By BMG Labtech
BMG LABTECH has developed the new reference multi-mode microplate PHERAstar® FSX reader for HTS applications. This reader was specifically conceived for the fastest read times, the best sensitivity and unmatched flexibility in all plate formats up to 3456 wells...
16 March 2016 | By Victoria White
Researchers from NIST have shown that high-throughput screening can dramatically speed up the challenging task of antimicrobial discovery...
1 March 2016 | By Merck KGaA
With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analysing all the hallmarks of cancer...
23 February 2016 | By DiscoverX Corporation
PathHunter cell-based pharmacotrafficking assays provide a simple and quantitative tool for broad pharmacological characterisation and interrogation of compound function in disease processes associated with protein trafficking and internalization due to protein misfolding...
23 February 2016 | By DiscoverX Corporation
The most comprehensive kinase inhibitor screening panel with over 480 kinase assays to screen against on a single technology platform...
22 February 2016 | By DiscoverX Corporation
The KILR Cytotoxicity Assay is a simple, non-radioactive and dye-free method to specifically measure target cancer cell cytotoxicity...
22 February 2016 | By DiscoverX Corporation
GPCRscan is a functional cell-based GPCR assay panel for profiling drug compounds during drug discovery...
19 February 2016 | By DiscoverX Corporation
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA...
19 February 2016 | By DiscoverX Corporation
PathHunter® Checkpoint Assays enable screening and potency assays for the development of immunotherapy drugs...
A concise overview of some of the key features for the use of antibodies and immunochemical techniques in biological research...
In the past two decades, several alternative, non-radiometric assay formats have been developed for the high-throughput screening (HTS) of target classes such as protein kinases, which were previously screened using radiometric assays. Radiometric screening (and the expertise to perform such HTS) has thus declined in recent years...
Neglected tropical diseases pose a significant threat to public health and affect nearly one billion people in tropical and sub-tropical regions throughout the world. There is a pressing need to identify new therapeutics for NTDs and many developed nations are participating in drug discovery efforts...
12 February 2016 | By DiscoverX Corporation
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients...
